VPS Healthcare is planning to build a cancer hospital in the capital using the latest proton beam therapy.
It is part of a new medical city planned for Mohammed Bin Zayed City in Abu Dhabi.
The Abu Dhabi-based company’s founder and managing director, Dr Shamsheer Vayalil, revealed the plans following the signing of a with US-based health care provider Penn Medicine.
Under the deal, Penn Medicine will provide expertise for creating new systems, provide physicians and nursing staff and offer comprehensive training and development for VPS Healthcare’s staff. The deal will also help VPS Healthcare to develop its own oncology offer, as well as improve its treatment of diabetes and other chronic, lifestyle-related diseases and create a structure for VPS Healthcare’s nursing staff to gain accreditation under the American Nurses Credentialising Center’s Magnet programme.
“Oncology is one space where we were very interested to collaborate,” said Dr Vayalil. “They have already started looking at our systems and trying to make sure that we provide the entire service spectrum in our new project in Mohammed Bin Zayed City. That’s going to be a flagship hospital and we expect to have all of the latest technology in cancer, including a proton beam, which is only available in a few centres around the world,” he added.
Dr Vayalil said that VPS Healthcare has already begun to seek approval from Abu Dhabi Health Authority for using the treatment, and that he anticipates that that the hospital will open at the same time as the rest of its 1 million sq ft, 300-bed medical city planned for Mohammed Bin Zayed City, for which it gained planning approval from the Abu Dhabi Urban Planning Council earlier this year.
Mr Vayalil said this would be the first proton therapy centre in the Middle East, and would make its new hospital “a complete cancer care destination”.
“We feel that that’s where we need to add value for local patients, because it’s very difficult to travel when you are affected by these diseases.”
Meanwhile, Penn Healthcare’s CEO Ralph Muller said the VPS Healthcare treatment centre in the UAE would provide “a real opportunity” to provide additional research and insight for its own cancer programme.
Follow The National’s Business section on Twitter